Stockreport

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

Unicycive Therapeutics, Inc.  (UNCY) 
PDF – OLC New Drug Application (NDA) Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025– – Commercial Planning in Progress for 2025 Launch – [Read more]